{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:48:39Z","timestamp":1787028519609,"version":"build-2736575974"},"reference-count":114,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["KMUH108-8M42"],"award-info":[{"award-number":["KMUH108-8M42"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["KMUH111-1M36"],"award-info":[{"award-number":["KMUH111-1M36"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["DK-DK(A)112002"],"award-info":[{"award-number":["DK-DK(A)112002"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["MOST110-2314-B-037-072-MY3"],"award-info":[{"award-number":["MOST110-2314-B-037-072-MY3"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["MOST111-2314-B-037-078"],"award-info":[{"award-number":["MOST111-2314-B-037-078"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-037-004"],"award-info":[{"award-number":["NSTC 112-2320-B-037-004"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-037-064"],"award-info":[{"award-number":["NSTC 112-2314-B-037-064"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["KMUH108-8M42"],"award-info":[{"award-number":["KMUH108-8M42"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["KMUH111-1M36"],"award-info":[{"award-number":["KMUH111-1M36"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["DK-DK(A)112002"],"award-info":[{"award-number":["DK-DK(A)112002"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["MOST110-2314-B-037-072-MY3"],"award-info":[{"award-number":["MOST110-2314-B-037-072-MY3"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["MOST111-2314-B-037-078"],"award-info":[{"award-number":["MOST111-2314-B-037-078"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-037-004"],"award-info":[{"award-number":["NSTC 112-2320-B-037-004"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University, Kaohsiung, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-037-064"],"award-info":[{"award-number":["NSTC 112-2314-B-037-064"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan","award":["KMUH108-8M42"],"award-info":[{"award-number":["KMUH108-8M42"]}]},{"name":"National Science and Technology Council, Taiwan","award":["KMUH111-1M36"],"award-info":[{"award-number":["KMUH111-1M36"]}]},{"name":"National Science and Technology Council, Taiwan","award":["DK-DK(A)112002"],"award-info":[{"award-number":["DK-DK(A)112002"]}]},{"name":"National Science and Technology Council, Taiwan","award":["MOST110-2314-B-037-072-MY3"],"award-info":[{"award-number":["MOST110-2314-B-037-072-MY3"]}]},{"name":"National Science and Technology Council, Taiwan","award":["MOST111-2314-B-037-078"],"award-info":[{"award-number":["MOST111-2314-B-037-078"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 112-2320-B-037-004"],"award-info":[{"award-number":["NSTC 112-2320-B-037-004"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 112-2314-B-037-064"],"award-info":[{"award-number":["NSTC 112-2314-B-037-064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Thalassemia is a heterogeneous congenital hemoglobinopathy common in the Mediterranean region, Middle East, Indian subcontinent, and Southeast Asia with increasing incidence in Northern Europe and North America due to immigration. Iron overloading is one of the major long-term complications in patients with thalassemia and can lead to organ damage and carcinogenesis. Hepatocellular carcinoma (HCC) is one of the most common malignancies in both transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT). The incidence of HCC in patients with thalassemia has increased over time, as better chelation therapy confers a sufficiently long lifespan for the development of HCC. The mechanisms of iron-overloading-associated HCC development include the increased reactive oxygen species (ROS), inflammation cytokines, dysregulated hepcidin, and ferroportin metabolism. The treatment of HCC in patients with thalassemia was basically similar to those in general population. However, due to the younger age of HCC onset in thalassemia, regular surveillance for HCC development is mandatory in TDT and NTDT. Other supplemental therapies and experiences of novel treatments for HCC in the thalassemia population were also reviewed in this article.<\/jats:p>","DOI":"10.3390\/ijms241612654","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T10:11:22Z","timestamp":1691662282000},"page":"12654","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies"],"prefix":"10.3390","volume":"24","author":[{"given":"Pei-Chin","family":"Lin","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan"},{"name":"School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Yi","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yi","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-0505","authenticated-orcid":false,"given":"Shih-Hsien","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"},{"name":"Center of Applied Genomics, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-9116","authenticated-orcid":false,"given":"Shyh-Shin","family":"Chiou","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan"},{"name":"Center of Applied Genomics, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan"},{"name":"Division of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807378, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Steinberg, M.H., Forget, B.G., Higgs, D.R., and Weatherall, D.J. (2009). Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, Cambridge University Press.","DOI":"10.1017\/CBO9780511596582"},{"key":"ref_2","first-page":"4331","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ejh.13512","article-title":"Changing patterns in the epidemiology of \u03b2-thalassemia","volume":"105","author":"Kattamis","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher","year":"2018","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMra1404415","article-title":"The \u03b1-thalassemias","volume":"371","author":"Piel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2017.1.265","article-title":"Iron overload in thalassemia: Different organs at different rates","volume":"2017","author":"Taher","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program Book"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"\u03b2-Thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03630260500455565","article-title":"A prospective study of hepatocellular carcinoma incidence in thalassemia","volume":"30","author":"Mancuso","year":"2006","journal-title":"Hemoglobin"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.30462","article-title":"Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review","volume":"123","author":"Moukhadder","year":"2017","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/jech-2014-205075","article-title":"Thalassaemia and risk of cancer: A population-based cohort study","volume":"69","author":"Chung","year":"2015","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_14","unstructured":"Taher, A., Musallam, K., and Cappellini, M.D. (2017). Guidelines for the Management of Non-Transfusion Dependent Thalassaemia (NTDT), TIF Publications."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","author":"Sangiovanni","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-156-12-201206190-00004","article-title":"Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: A Danish nationwide cohort study","volume":"156","author":"Jepsen","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.11.045","article-title":"Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis","volume":"58","author":"Lin","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14309\/ajg.0000000000000966","article-title":"Alcohol intake and mortality in patients with chronic viral hepatitis: A nationwide cohort study","volume":"116","author":"Sinn","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.13009","article-title":"Hepatocellular carcinoma in thalassaemia: An update of the Italian Registry","volume":"167","author":"Garani","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jcp.43.8.638","article-title":"Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major","volume":"43","author":"Wonke","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6573497","DOI":"10.1155\/2019\/6573497","article-title":"Elevated prevalence of abnormal glucose metabolism and other endocrine disorders in patients with-thalassemia major: A meta-analysis","volume":"2019","author":"He","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1031633","DOI":"10.3389\/fendo.2022.1031633","article-title":"Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology","volume":"13","author":"Memaj","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fphys.2019.01294","article-title":"Hepcidin and anemia: A tight relationship","volume":"10","author":"Pagani","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Frey, P.A., and Reed, G.H. (2012). The Ubiquity of Iron, ACS Publications.","DOI":"10.1021\/cb300323q"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: Regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/gim.2017.121","article-title":"Clinical penetrance in hereditary hemochromatosis: Estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes","volume":"20","author":"Grosse","year":"2018","journal-title":"Genet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1001\/jama.2020.21566","article-title":"Association of hemochromatosis HFE p. C282Y homozygosity with hepatic malignancy","volume":"324","author":"Atkins","year":"2020","journal-title":"JAMA"},{"key":"ref_34","first-page":"446","article-title":"Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver","volume":"22","author":"Turlin","year":"1995","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/nyas.13005","article-title":"Malignancies and thalassemia: A review of the literature","volume":"1368","author":"Zanella","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The mechanisms of HBV-induced hepatocellular carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-021-00279-w","article-title":"Overcoming vaccine hesitancy in low-income and middle-income regions","volume":"7","author":"Simas","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_38","unstructured":"Xie, Y. (2017). Infectious Agents Associated Cancers: Epidemiology and Molecular Biology, Springer."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677926","DOI":"10.3389\/fonc.2021.677926","article-title":"Epigenetic mechanisms involved in HCV-induced hepatocellular carcinoma (HCC)","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_40","first-page":"35","article-title":"Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma","volume":"6","author":"Benhammou","year":"2020","journal-title":"Hepatoma Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5306\/wjco.v8.i6.429","article-title":"Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"8","author":"Said","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"984728","DOI":"10.3389\/fimmu.2022.984728","article-title":"Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.3390\/ijms22094495","article-title":"Metabolic spectrum of liver failure in type 2 diabetes and obesity: From NAFLD to NASH to HCC","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trecan.2020.08.005","article-title":"Cirrhosis: A questioned risk factor for hepatocellular carcinoma","volume":"7","author":"Garrido","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB\u2013regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI44490","article-title":"An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice","volume":"121","author":"Sindrilaru","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2013.01.021","article-title":"Prognostic gene expression signature for patients with hepatitis C\u2013related early-stage cirrhosis","volume":"144","author":"Hoshida","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","article-title":"Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment","volume":"10","author":"Budhu","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2019.07.028","article-title":"An immune gene expression signature associated with development of human hepatocellular carcinoma identifies mice that respond to chemopreventive agents","volume":"157","author":"Moeini","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1572-0241.2001.03472.x","article-title":"Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?","volume":"96","author":"Adams","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_54","first-page":"17","article-title":"Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation","volume":"100","author":"Angelucci","year":"2002","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_56","unstructured":"Moloney, J.N., and Cotter, T.G. (2018). Seminars in Cell & Developmental Biology, Elsevier."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/10715762.2016.1219352","article-title":"15-Deoxy-\u039412, 14-prostaglandin J2 stabilizes hypoxia inducible factor-1\u03b1 through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2","volume":"50","author":"Choi","year":"2016","journal-title":"Free Radic. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3892\/or.2016.5044","article-title":"Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK\/NF-\u03baB pathway","volume":"36","author":"Cao","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/jvh.12831","article-title":"A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization","volume":"25","author":"Lee","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1053\/j.gastro.2011.01.053","article-title":"Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C","volume":"140","author":"Lambrecht","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kijima, H., Sawada, T., Tomosugi, N., and Kubota, K. (2008). Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-167"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3181\/0807-RM-227","article-title":"Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences","volume":"234","author":"Tan","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00432-009-0585-5","article-title":"Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications","volume":"135","author":"Tseng","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jhep.2014.10.046","article-title":"Hepatic hepcidin expression is decreased in cirrhosis and HCC","volume":"62","author":"Kessler","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1038\/ncomms13817","article-title":"Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt","volume":"7","author":"Han","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41416-022-01753-2","article-title":"Hepcidin in hepatocellular carcinoma","volume":"127","author":"Joachim","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.cellsig.2014.07.029","article-title":"Disordered hepcidin-ferroportin signaling promotes breast cancer growth","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/abbs\/gmv063","article-title":"An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis","volume":"47","author":"Guo","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Rah, B., Farhat, N.M., Hamad, M., and Muhammad, J.S. (2023). JAK\/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: Therapeutic implications. Clin. Exp. Med.","DOI":"10.1007\/s10238-023-01047-8"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.3390\/ijms19124070","article-title":"Hepatocellular carcinoma in \u03b2-thalassemia patients: Review of the literature with molecular insight into liver carcinogenesis","volume":"19","author":"Finianos","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00277-020-04379-7","article-title":"Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent \u03b2-thalassemia\/Hb E patients","volume":"100","author":"Hatairaktham","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/ptr.6118","article-title":"An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in \u03b2-thalassemia major patients: A double-blind randomized controlled clinical trial","volume":"32","author":"Mohammadi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_80","first-page":"1136","article-title":"Green tea influence on iron overload in thalassemia intermedia patients: A randomized controlled trial","volume":"9","author":"Hussein","year":"2020","journal-title":"FResearch"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"210629","DOI":"10.7754\/Clin.Lab.2021.210629","article-title":"The Effect of Curcumin on Iron Overload in Patients with Beta-Thalassemia Intermedia","volume":"68","author":"Saeidnia","year":"2022","journal-title":"Clin. Lab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1097\/HS9.0000000000000732","article-title":"2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia","volume":"6","author":"Farmakis","year":"2022","journal-title":"HemaSphere"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_84","first-page":"7","article-title":"Hepatocellular carcinoma. Nat Rev Dis Primers","volume":"7","author":"Llovet","year":"2021","journal-title":"PubMed Artic."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000507370","article-title":"A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements","volume":"9","author":"Kudo","year":"2020","journal-title":"Liver Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1159\/000517393","article-title":"Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria","volume":"10","author":"Hung","year":"2021","journal-title":"Liver Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","article-title":"Hepatocellular carcinoma in the thalassaemia syndromes","volume":"124","author":"Vergine","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2020013","DOI":"10.4084\/mjhid.2020.013","article-title":"Characteristics and prognosis of hepatocellular carcinoma in multi-transfused patients with \u03b2-thalassemia. Experience of a single tertiary center","volume":"12","author":"Papadopoulos","year":"2020","journal-title":"Mediterr. J. Hematol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00270-022-03084-4","article-title":"Percutaneous Microwave Ablation for the Management of Hepatocellular Carcinoma in Transfusion-Dependent Beta-Thalassemia Patients","volume":"45","author":"Filippiadis","year":"2022","journal-title":"CardioVascular Interv. Radiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00277-021-04511-1","article-title":"Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: Not a disappearing entity","volume":"100","author":"Ricchi","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1665-2681(19)31397-3","article-title":"Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis","volume":"12","author":"Maakaron","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2010.08180.x","article-title":"Hepatocellular carcinoma in patients with thalassaemia syndromes: Clinical characteristics and outcome in a long term single centre experience","volume":"150","author":"Renda","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13098","article-title":"Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?","volume":"168","author":"Mancuso","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mangia, A., Bellini, D., Cillo, U., Laghi, A., Pelle, G., Valori, V.M., and Caturelli, E. (2020). Hepatocellular carcinoma in adult thalassemia patients: An expert opinion based on current evidence. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01391-z"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/cancers15061680","article-title":"Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives","volume":"15","author":"Girardi","year":"2023","journal-title":"Cancers"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/JHC.S300182","article-title":"Hepatocellular carcinoma: An overview of the changing landscape of treatment options","volume":"8","author":"Koulouris","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jgh.15889","article-title":"Personalized treatment for hepatocellular carcinoma: Current status and Future perspectives","volume":"37","author":"Chan","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3748\/wjg.v24.i39.4436","article-title":"Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer","volume":"24","author":"Sagar","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Goltyaev, M.V., and Varlamova, E.G. (2023). The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310547"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ding, J., and Wen, Z. (2021). Survival improvement and prognosis for hepatocellular carcinoma: Analysis of the SEER database. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08904-3"},{"key":"ref_105","first-page":"1781","article-title":"How I manage medical complications of \u03b2-thalassemia in adults","volume":"132","author":"Taher","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2020006","DOI":"10.4084\/mjhid.2020.006","article-title":"A concise review on the frequency, major risk factors and surveillance of hepatocellular carcinoma (HCC) in \u03b2-thalassemias: Past, present and future perspectives and the ICET-A experience","volume":"12","author":"Soliman","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0016-5085(85)90324-5","article-title":"Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications","volume":"89","author":"Sheu","year":"1985","journal-title":"Gastroenterology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: A meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological BiomarkersDetection of Hepatocellular Carcinoma","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1016952","DOI":"10.3389\/fonc.2022.1016952","article-title":"HCC biomarkers\u2013state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice","volume":"12","author":"Schlosser","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.3390\/ijms24054286","article-title":"Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review","volume":"24","author":"Shahini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2159-8290.CD-22-0659","article-title":"Detecting liver cancer using cell-free DNA fragmentomes","volume":"13","author":"Foda","year":"2023","journal-title":"Cancer Discov."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"100304","DOI":"10.1016\/j.jhepr.2021.100304","article-title":"Using cell-free DNA for HCC surveillance and prognosis","volume":"3","author":"Tran","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.32308","article-title":"Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12654\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:30:43Z","timestamp":1760128243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":114,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241612654"],"URL":"https:\/\/doi.org\/10.3390\/ijms241612654","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}